Nuvalent, Inc.
Total Trades
254
Buys
2
Sells
142
Largest Trade
N/A
Insiders
10
Institutional Funds
183
Inst. Value
$1M+
Activist Filings
24
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 6K | $27.85 | Mar 2, 2026 |
| Noci Darlene | Chief Development … | SELL | $500K+ | 6K | $103.03 | Mar 2, 2026 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $15K–$50K | 6K | $6.89 | Mar 2, 2026 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $500K+ | 6K | $103.05 | Mar 2, 2026 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 6K | $27.85 | Feb 2, 2026 |
| Noci Darlene | Chief Development … | SELL | $500K+ | 6K | $102.08 | Feb 2, 2026 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $100K–$500K | 15K | $27.85 | Jan 23, 2026 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $1M+ | 15K | $110.15 | Jan 23, 2026 |
| Pelish Henry E. | Chief Scientific O… | SELL | $500K+ | 5K | $97.24 | Jan 7, 2026 |
| Pelish Henry E. | Chief Scientific O… | GRANT | N/A | 18K | — | Jan 7, 2026 |
| Noci Darlene | Chief Development … | SELL | $500K+ | 7K | $97.25 | Jan 7, 2026 |
| Noci Darlene | Chief Development … | GRANT | N/A | 18K | — | Jan 7, 2026 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $500K+ | 7K | $97.26 | Jan 7, 2026 |
| Miller Deborah Ann | Chief Legal Officer | GRANT | N/A | 18K | — | Jan 7, 2026 |
| Turner Christopher Durant | Chief Medical Offi… | SELL | $500K+ | 7K | $97.25 | Jan 7, 2026 |
| Turner Christopher Durant | Chief Medical Offi… | GRANT | N/A | 18K | — | Jan 7, 2026 |
| Balcom Alexandra | CFO | GRANT | N/A | 18K | — | Jan 7, 2026 |
| Balcom Alexandra | CFO | SELL | $500K+ | 7K | $97.25 | Jan 7, 2026 |
| Porter James Richard | President and CEO | GRANT | N/A | 46K | — | Jan 7, 2026 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $97.26 | Jan 7, 2026 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $1M+ | 10K | $100.51 | Jan 5, 2026 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $100K–$500K | 10K | $18.93 | Jan 5, 2026 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $100.04 | Jan 2, 2026 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Jan 2, 2026 |
| Balcom Alexandra | CFO | SELL | $500K+ | 7K | $110.32 | Dec 10, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Dec 2, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $108.58 | Dec 2, 2025 |
| Shair Matthew | Director | SELL | $500K+ | 8K | $109.37 | Nov 26, 2025 |
| Flynn James E | Director | SELL | $1M+ | 743K | $95.44 | Nov 25, 2025 |
| Balcom Alexandra | CFO | SELL | $1M+ | 21K | $99.62 | Nov 19, 2025 |
| Balcom Alexandra | CFO | EXERCISE | $1M+ | 21K | $50.64 | Nov 19, 2025 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $100K–$500K | 24K | $6.89 | Nov 19, 2025 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $1M+ | 24K | $105.50 | Nov 19, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $102.92 | Oct 31, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Oct 31, 2025 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $100K–$500K | 22K | $6.89 | Oct 31, 2025 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $1M+ | 22K | $103.16 | Oct 31, 2025 |
| Shair Matthew | Director | SELL | $1M+ | 60K | $100.26 | Oct 29, 2025 |
| Miller Deborah Ann | Chief Legal Officer | EXERCISE | $15K–$50K | 5K | $6.89 | Oct 22, 2025 |
| Miller Deborah Ann | Chief Legal Officer | SELL | $100K–$500K | 5K | $94.91 | Oct 22, 2025 |
| Balcom Alexandra | CFO | EXERCISE | $100K–$500K | 28K | $6.89 | Oct 2, 2025 |
| Balcom Alexandra | CFO | SELL | $1M+ | 28K | $85.05 | Oct 2, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $83.07 | Oct 2, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Oct 2, 2025 |
| Porter James Richard | President and CEO | EXERCISE | $500K+ | 27K | $18.93 | Sep 17, 2025 |
| Porter James Richard | President and CEO | SELL | $1M+ | 27K | $79.08 | Sep 17, 2025 |
| Pelish Henry E. | Chief Scientific O… | EXERCISE | $100K–$500K | 4K | $26.94 | Sep 12, 2025 |
| Pelish Henry E. | Chief Scientific O… | SELL | $100K–$500K | 4K | $78.83 | Sep 12, 2025 |
| Noci Darlene | Chief Development … | SELL | $100K–$500K | 4K | $74.62 | Aug 27, 2025 |
| Noci Darlene | Chief Development … | EXERCISE | $100K–$500K | 4K | $27.85 | Aug 27, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 183 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.9M | $1M+ | SH |
| STATE STREET CORP | 1.9M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 1.7M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| BRAIDWELL LP | 821K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 785K | $1M+ | SH |
| Fairmount Funds Management LLC | 728K | $1M+ | SH |
| NORGES BANK | 574K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 453K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 374K | $1M+ | SH |
| First Turn Management, LLC | 369K | $1M+ | SH |
| Candriam S.C.A. | 358K | $1M+ | SH |
| Pictet Asset Management Holding SA | 356K | $1M+ | SH |
| Affinity Asset Advisors, LLC | 323K | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 311K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 296K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 272K | $1M+ | SH |
| Defilade Capital Management, L.P. | 269K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 174K | $1M+ | SH |
| Aberdeen Group plc | 165K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 12, 2026
24.2%
22.9M shares
SC 13G · Jul 18, 2025
5.0%
3.3M shares
SC 13G/A · Apr 29, 2025
4.5%
2.9M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 13, 2025
27.6%
23.6M shares
SC 13G/A · Jan 31, 2025
6.8%
4.5M shares
SC 13G/A · Nov 14, 2024
4.6%
3.0M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Nov 8, 2024
5.6%
3.6M shares
SC 13G · Oct 24, 2024
5.6%
3.6M shares
Deerfield Management Company, L.P.
SC 13G/A · May 15, 2024
34.0%
25.6M shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13D/A · Mar 29, 2024
4.1%
2.4M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2024
3.4%
1.9M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.7%
3.3M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 12, 2024
35.0%
25.5M shares
SC 13G · Jan 2, 2024
5.1%
2.9M shares
Paradigm Biocapital Advisors LP (Filed by)
SC 13G · Oct 30, 2023
0.0%
0 shares
Bain Capital Life Sciences Fund II, L.P. 2
SC 13D/A · Oct 20, 2023
4.2%
2.4M shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2023
5.5%
2.8M shares
Deerfield Management Company, L.P.
SC 13G/A · Feb 10, 2023
39.3%
25.5M shares
Deerfield Management Company, L.P.
SC 13G/A · Nov 14, 2022
39.2%
25.5M shares
Fairmount Funds Management LLC
SC 13G · Nov 9, 2022
5.1%
2.6M shares
Bain Capital Life Sciences Fund II, L.P.
SC 13D/A · Nov 3, 2022
4.8%
2.4M shares
Deerfield Management Company, L.P.
SC 13G · Feb 11, 2022
45.1%
24.8M shares